BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Park H, Park JY, Kim SU, Kim DY, Han KH, Chon CY, Ahn SH. Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir. World J Gastroenterol 2013; 19(43): 7671-7679 [PMID: 24431895 DOI: 10.3748/wjg.v19.i43.7671]
URL: https://www.wjgnet.com/1007-9327/full/v19/i43/7671.htm
Number Citing Articles
1
Sangheun Lee, Jun Yong Park, Kijun Song, Do Young Kim, Beom Kyung Kim, Seung Up Kim, Hye Jin Ku, Kwang-Hyub Han, Sang Hoon Ahn. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis BGut and Liver 2015; 9(6): 776 doi: 10.5009/gnl14297
2
Yan Xu, Yong-Gui Zhang, Xu Wang, Wen-Qian Qi, Shao-You Qin, Zhen-Hua Liu, Jian Jiao, Jiang-Bin Wang. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosisWorld Journal of Gastroenterology 2015; 21(25): 7869-7876 doi: 10.3748/wjg.v21.i25.7869
3
Si-Si Yang, Cheng-Wei Cai, Xue-Qing Ma, Jia Xu, Cheng-Bo Yu. Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysisHepatobiliary & Pancreatic Diseases International 2020; 19(6): 507 doi: 10.1016/j.hbpd.2020.09.007
4
Sangheun Lee, Jun Yong Park, Do Young Kim, Beom Kyung Kim, Seung Up Kim, Kijun Song, Hye Jin Ku, Kwang‐Hyub Han, Sang Hoon Ahn. Prediction of virologic response to tenofovir mono‐rescue therapy for multidrug resistant chronic hepatitis BJournal of Medical Virology 2016; 88(6): 1027 doi: 10.1002/jmv.24427
5
KASL clinical practice guidelines: management of chronic hepatitis BClinical and Molecular Hepatology 2016; 22(1): 18 doi: 10.3350/cmh.2016.22.1.18